Cargando…
Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
Hepatocellular carcinoma (HCC) has one of highest mortalities globally amongst cancers, but has limited therapeutic options once in the advanced stage. Hepatitis B or C virus infection are the most common drivers for HCC carcinogenesis, triggering chronic liver inflammation and adding to the complex...
Autores principales: | Bonilla, Cecilia Monge, McGrath, Nicole A., Fu, Jianyang, Xie, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597818/ https://www.ncbi.nlm.nih.gov/pubmed/33134550 http://dx.doi.org/10.20517/2394-5079.2020.58 |
Ejemplares similares
-
Systemic treatment options for advanced biliary tract carcinoma
por: Xie, Changqing, et al.
Publicado: (2020) -
Targeting cancer stem cells in cholangiocarcinoma (Review)
por: McGrath, Nicole A., et al.
Publicado: (2020) -
Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010) -
TSPAN8 and distant metastasis of nasopharyngeal carcinoma cells
por: Xie, Changqing, et al.
Publicado: (2020) -
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma
por: Monge, Cecilia, et al.
Publicado: (2021)